Roche Respiratory Solutions in the UK and Ireland

Roche Total Respiratory Solutions

Helping you transform what's possible with respiratory testing

Roche Respiratory Solutions can assist experts in diagnosing, correctly treating, and discharging patients faster, potentially easing the burden on healthcare professionals and helping to reduce winter pressures. 

Rapid respiratory test results help empower clinicians to deliver treatment at the earliest possible stage – potentially reducing the risk of escalation and improving patient outcomes. 

The Roche solution includes tests, technologies and transformation support for introducing rapid respiratory testing into any clinical setting - bringing care closer to the patient.

Enhancing care across all pathways

Our respiratory solutions are proven to deliver accurate diagnostics where they are needed most; in the community, in clinics, in hospitals, and helping to protect high-risk patients.

The image displays a series of Roche respiratory solutions increasing in size from left to right, with corresponding descriptions: "LumiraDx", "cobas Liat system, "cobas ePlex system", "cobas 5800 system", "cobas 6800 system", and cobas 8800 system". Below this, a horizontal blue line separates the solutions from a row of icons, each labeled with a different healthcare setting: "Pharmacy", "GP Practice", "Accident & Emergency", "Hospital wards", "Hospital laboratory", "Community hub testing", and "Reference laboratory". The overall image shows a portfolio of Roche respiratory solutions suitable for various healthcare settings

It all starts with a conversation

Please complete this form, and a team member will be in touch.

References

1. Abdel-Aal A et al. Prioritising primary care respiratory research needs: results from the 2020 International Primary Care Respiratory Group (IPCRG) global e-Delphi exercise. NPJ Prim Care Respir Med. 2022 Jan 28;32:6.

2. (2024). Roche.  Available at: https://diagnostics.roche.com/global/en/products/instruments/cobas-8800-ins-2694.html (Accessed: 2 October 2024).

3. Cooke J, et al. BMJ Open Resp Res. 2015;2:e000086.

4. Lingervelder D, et al. Int J Clin Pract. 2019;73:e13392.

5. Thornton HV, et al. British Journal of General Practice. 2020;70(701):574-575.

6. Schols AMR, et al. British Journal of General Practice. 2018;68(673):362-363.

7. Mills SEE, et al. BJGP Open. 2024;8(2):BJGPO.2023.0094.

8. Turner PJ, et al. Family Practice. 2016;33(4):388–394.

9. LumiraDx Product Insert SARS-CoV-2 Ag (version 14, 2022)

10. LumiraDx Product Insert SARS-CoV-2 Ag Ultra (version 1, 2022-07)

11. LumiraDx Product Insert SARS-CoV-2 & Flu A/B (version 5, 2022)

12. LumiraDx Product Insert SARS-CoV-2 & RSV (version 3, 2023-08)

13. cobas® Influenza A/B & RSV Product Insert

14. cobas® SARS-C0V-2 Product Insert

15. cobas® SARS-C0V-2 & Influenza A/B Product Insert